articleThe LancetMar 1, 2008Closed access

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

JAJohn A. OrmistonPWPatrick W. SerruysEREvelyn RegarDDDariusz DudekLTLeif Thuesen

Auckland City Hospital · Erasmus University Rotterdam · +6 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

715
total citations
FWCI
59.18
Percentile
100%
References
31
Citations per year

Authors

10

Topics & keywords

Topics
Keywords
  • Medicine
  • Stent
  • Intravascular ultrasound
  • Myocardial infarction
  • Everolimus
  • Clinical endpoint
  • Target lesion
  • Drug-eluting stent
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding